STOCK TITAN

Generac president sells 400 shares in 10b5-1 plan

President Generac Home Norman P. Taffe exercised options and sold 400 GNRC shares on September 8, 2026 under a pre-arranged Rule 10b5-1 trading plan.

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

GENERAC HOLDINGS INC. (GNRC) reported insider transactions by Norman P. Taffe, President Generac Home, on September 8, 2026. He exercised stock options to acquire 100 shares of common stock at an exercise price of $119.54 per share and sold a total of 400 shares of common stock at prices of $188.27 and $190.00 per share. The option exercise left him with 2,270 option-based shares reported as remaining. These sales were made under a Rule 10b5-1(c) trading plan adopted on March 6, 2026, indicating they were pre-arranged rather than discretionary trades.

Positive

  • None.

Negative

  • None.
Insider Taffe Norman P
Role President Generac Home
Sold 400 shs ($75K)
Approx. gross sale proceeds $75K
Approx. exercise cost $12K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F3 100 $0.00 $0.00
Sale Common Stock F1, F2 200 $188.27 $38K
Sale Common Stock F1 100 $188.27 $19K
Exercise Common Stock F1 100 $119.54 $12K
Sale Common Stock F1 100 $190.00 $19K
Holdings After Transaction: Stock Option (Right to Buy) — 2,270 contracts (Direct); Common Stock — 11,276 shares (Direct)
Footnotes (3)
  1. F1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
  2. F2. Multiple lots for the same price for this order have been combined.
  3. F3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
Common shares sold 400 shares Total Generac common shares sold by Norman P. Taffe on September 8, 2026
Sale prices $188.27 and $190.00 per share Per-share prices for Generac common stock sales on September 8, 2026
Options exercised 100 shares Shares of Generac common stock acquired through option exercise by Norman P. Taffe
Option exercise price $119.54 per share Exercise price for the 100 Generac shares obtained via stock option exercise
Remaining option-based shares 2,270 shares Option-related shares reported as held by Norman P. Taffe after the derivative exercise
Option expiration date March 1, 2033 Expiration date of the stock option from which 100 shares were exercised
Rule 10b5-1 plan adoption date March 6, 2026 Adoption date of the trading plan governing the reported sales
Rule 10b5-1(c) plan regulatory
"Adoption date of referenced 10b5-1(c) plan is: 03-06-2026"
graded vesting schedule financial
"Grant has a graded vesting schedule. Date exercisable will vary"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

What insider transactions did GNRC executive Norman P. Taffe report on this Form 4?

Norman P. Taffe reported exercising stock options for 100 shares of Generac common stock at an exercise price of $119.54 per share and selling a total of 400 shares of common stock at prices of $188.27 and $190.00 per share on September 8, 2026.

Were Norman P. Taffe’s GNRC stock sales made under a Rule 10b5-1 plan?

Yes. The filing states that the reported transactions were executed pursuant to a Rule 10b5-1(c) trading plan with an adoption date of March 6, 2026, indicating the trades were pre-arranged rather than initiated at the time of sale.

How many GNRC shares did Norman P. Taffe sell in this Form 4 filing?

Norman P. Taffe sold a total of 400 shares of Generac common stock on September 8, 2026, in three separate sale transactions, at per-share prices of $188.27 and $190.00, as disclosed in the Form 4 data.

What options did Norman P. Taffe exercise for GNRC stock?

He exercised stock options covering 100 shares of Generac common stock at an exercise price of $119.54 per share. The derivative position has a reported expiration date of March 1, 2033 and a graded vesting schedule that varies by tranche.

How many option-based GNRC shares does Norman P. Taffe hold after the reported exercise?

After the reported option exercise, Norman P. Taffe is shown as holding 2,270 option-based shares tied to the reported stock option award. This figure reflects the remaining derivative-related shares as disclosed in the Form 4 data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Taffe Norman P

(Last)(First)(Middle)
S45 W29290 HWY.59
C/O GENERAC HOLDINGS INC.

(Street)
WAUKESHA WISCONSIN 53189

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President Generac Home
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/08/2026S(1)(2)200D$188.2711,376D
Common Stock09/08/2026S(1)100D$188.2711,276D
Common Stock09/08/2026M(1)100A$119.5411,376D
Common Stock09/08/2026S(1)100D$19011,276D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$119.5409/08/2026M100 (3)03/01/2033Common Stock100$02,270D
Explanation of Responses:
1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
2. Multiple lots for the same price for this order have been combined.
3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
/s/ Raj Kanuru, Attorney in Fact09/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading